Patents by Inventor Ali Naji

Ali Naji has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20130028897
    Abstract: The invention provides a method for reducing the level of alloantibodies in a sensitized patient awaiting kidney transplantation by administering Belimumab or an antibody that specifically binds a B-lymphocyte stimulator protein (BLyS). The invention further provides a method for reducing the risk of an allograft rejection in an allograft recipient by administering Belimumab or an antibody that specifically binds a BLyS.
    Type: Application
    Filed: April 27, 2010
    Publication date: January 31, 2013
    Inventor: Ali Naji
  • Patent number: 8362224
    Abstract: This invention is directed to a marker gene for autoimmune disease. Specifically, the invention is directed to the use of a polymorph of CD93 in methods and compositions for the detection, prognosis and therapy of Type I Diabetes and systemic lupus erythematosus (SLE).
    Type: Grant
    Filed: December 19, 2007
    Date of Patent: January 29, 2013
    Assignee: The Trustees of the University of Pennsylvania
    Inventors: Hooman Noorchashm, Ali Naji
  • Publication number: 20110014608
    Abstract: This invention is directed to a marker gene for autoimmune disease. Specifically, the invention is directed to the use of a polymorph of CD93 in methods and compositions for the detection, prognosis and therapy of Type I Diabetes and systemic lupus erythematosus (SLE).
    Type: Application
    Filed: December 19, 2007
    Publication date: January 20, 2011
    Applicant: THE TRUSTEES OF THE UNIVESITY OF PENNSYLVANIA
    Inventors: Hooman Noorchashm, Ali Naji
  • Publication number: 20100272697
    Abstract: A composition comprising islet cells and an extracellular matrix component as well as methods of transplanting same are described. Retroperitoneal and subcutaneous islet cells transplants maintain their viability and increased insulin production for prolonged periods of time.
    Type: Application
    Filed: April 10, 2008
    Publication date: October 28, 2010
    Inventors: Ali Naji, Ming Yu, Chengyang Liu, Hoorman Noorchashm, Omaida C. Velazquez